Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis

Muscle and Nerve

Volumn 20, Issue 1, 1997, Pages 45-51

  Azzouz, Mimoun ^a   Leclerc, Nathalie ^a   Gurney, Mark ^b   Warter, Jean Marie ^c   Poindron, Philippe ^a   Borg, Jacques ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b PFIZER INC   (United States)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

amyotrophic lateral sclerosis; Cu,Zn superoxide dismutase; electromyography; motor neuron disease; motor unit

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ELECTROMYOGRAM; GASTROCNEMIUS MUSCLE; GENETIC PREDISPOSITION; MALE; MOTOR NEURON DISEASE; MOTOR UNIT; MOUSE; MUSCLE WEAKNESS; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC ANIMAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS; MALE; MICE; MICE, TRANSGENIC; MOTOR NEURON DISEASE; REACTION TIME;

EID: 0031014470     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H     Document Type: Article

References (21)

1. Andersen PM, Nislsson P, Ala-Hurula V, Keränen ML, Tarvainen I, Haltia T, Nilsson L, Binzer M, Forsgren L, Marklund S: Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in Cu,Zn superoxide dismutase. Nat Gene 1995;10:61-66.
2. Azzouz M, Kennel FP, Warter JM, Poindron P, Borg J: Enhancement of mouse sciatic nerve regeneration by the long chain fatty alcohol, N-hexacosanol. Exp Neurol 1996;138:189-197.
3. Brown RH Jr: Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function. Curr Biol 1995;5:841-846.
4. Chiu AY, Zhai P, Dalcanto MC, Peters TM, Kwon YW, Prattis SM, Gurney ME: Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 1995;6:349-362.
5. Dal Canto MC, Gurney M: Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing mid-type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995;676:25-40.
6. Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B, Roos RP, Warner C, Deng G, Soriano E, Smyth C, Parge HE, Ahmed A, Roses AD, Hallewell RA, Pericak-Vance MA, Siddique T: Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993;261:1047-1051.
7. Dimitru D, DeLisa JA: AAEM minimonograph #10: Volume conduction. Muscle Nerve 1991;14:605-624.
8. Griffin JW: Motor neuron disease. Trends Neurosci 1995;18:513-514.
9. Gurney M, Pu H, Chiu A, Dal Canto M, Polchow C, Alexander D, Caliendo J, Hantati A, Kwon Y, Deng H, Chen W, Zhai P, Sifit R, Siddique T: Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994;264:1772-1775.
10. Gurney M, Cutting FB, Zhai P, Doble A, Taylor C, Andrus PK, Hall ED: Benefit of vitamin E, Riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996;39:147-157.
11. Kennel PF, Fonteneau P, Martin E, Schmidt JM, Azzouz M, Borg J, Guenet JL, Schmalbruch H, Warter JM, Poindron P: Electromyographical and motor performance studies in the pmn model of neurodegenerative disease. Neurobiol Dis 1996;3:137-147.
12. Kim YI, Gurney ME: Transgenic animal model of amyotrophic lateral sclerosis: enhanced release of acetylcholine from the motor nerve terminals. Abst Soc Neurosci 1995;21:1005.
13. McComas AJ: Invited review: Motor unit estimation: methods, results, and present status. Muscle Nerve 1991;14:585-597.
14. Mulder DW, Kurland LT, Oflbrd KP, Beard CM: Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 1986;36:511-517.
15. Perry T, Hansen S, Jones K: Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 1987;37:1845-1848.
16. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL: Transgenic mice with increased Cu,Zn superoxide dismutase activity are resistent to N-methyl-4-phenyl-1,2,3,6-tetrahydropyidine-induced neurotoxicity. J Neurosci 1992;12:1658-1667.
17. Rosen D, Siddique T, Patterson D, Figlewicz D, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan J, Deng H, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston S, Berger R, Tanzi R, Halperin J, Herzfelt B, Van den Bergh R, Hung W, Bird T, Deng G, Mulder D, Smyth C, Laing N, Soriano E, Pericak-Vance M, Haines J, Rouleau G, Gusella J, Horvitz H, Brown R Jr: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
18. Rothstein JD, Vankammen M, Levey AI, Kuncl RW: Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84.
19. Rowland LP: Motor neuron diseases and amyotrophic lateral sclerosis: research progress. Trends Neurosci 1987;10:393-398.
20. Wong P, Pardo C, Borchelt D, Lee M, Copeland N, Jenkins N, Sisocia S, Cleveland D, Price D: An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995;14:1105-1116.
21. Yang G, Chan PH, Che J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H: Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 1994;25:165-170.